D.F. Gilpin
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cystic Fibrosis Research Advances 26
- Tracheal and airway disorders 7
-
- Bacterial biofilms and quorum sensing 10
- Gut microbiota and health 5
- Co-authors
- Michael M. Tunney (45 shared papers)J.S. Elborn (28 shared papers)Matthew C. Wolfgang (9 shared papers)Richard C. Boucher (6 shared papers)Marianne S. Muhlebach (11 shared papers)Erich Klem (3 shared papers)Anthony A. Fodor (2 shared papers)G. Döering (2 shared papers)
- Journals
- Journal of Cystic Fibrosis (9 papers)Journal of Hospital Infection (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Journal of Medical Microbiology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
D.F. Gilpin
53 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 137
- Molecular Medicine 188
- Applied Microbiology and Biotechnology 67
- Pulmonary and Respiratory Medicine 836
- Emergency Medical Services 163
- Infectious Diseases 416
Countries citing papers authored by D.F. Gilpin
This map shows the geographic impact of D.F. Gilpin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.F. Gilpin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.F. Gilpin more than expected).
Fields of papers citing papers by D.F. Gilpin
This network shows the impact of papers produced by D.F. Gilpin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.F. Gilpin. The network helps show where D.F. Gilpin may publish in the future.
Co-authors
The 25 scholars most cited alongside D.F. Gilpin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 352 | |
| 2 | 2012 | 283 | |
| 3 | 2011 | 132 | |
| 4 | 2003 | 103 | |
| 5 | 2011 | 73 | |
| 6 | 2006 | 63 | |
| 7 | 2009 | 59 | |
| 8 | 2013 | 57 | |
| 9 | 2010 | 56 | |
| 10 | 2015 | 51 | |
| 11 | 2006 | 51 | |
| 12 | 2008 | 46 | |
| 13 | 2019 | 39 | |
| 14 | 2017 | 37 | |
| 15 | 2013 | 35 | |
| 16 | 2019 | 35 | |
| 17 | 2010 | 32 | |
| 18 | 2012 | 30 | |
| 19 | 2014 | 30 | |
| 20 | 2021 | 29 |
About D.F. Gilpin
D.F. Gilpin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Infectious Diseases, Epidemiology and Clinical Biochemistry, having authored 57 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (26 papers), Bacterial biofilms and quorum sensing (10 papers), Tracheal and airway disorders (7 papers), Bacterial Identification and Susceptibility Testing (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Nosocomial Infections in ICU (5 papers), Animal Virus Infections Studies (5 papers) and Gut microbiota and health (5 papers). The work is most often cited by research in Molecular Medicine (188 citations), Applied Microbiology and Biotechnology (67 citations), Pulmonary and Respiratory Medicine (836 citations), Emergency Medical Services (163 citations) and Infectious Diseases (416 citations). D.F. Gilpin has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Michael M. Tunney, J.S. Elborn, Matthew C. Wolfgang, Richard C. Boucher, Marianne S. Muhlebach, Erich Klem, Anthony A. Fodor, G. Döering, T. Fintan Moriarty and Sheila Patrick. Their work appears in journals such as Journal of Cystic Fibrosis, Journal of Hospital Infection, Journal of Antimicrobial Chemotherapy, Journal of Medical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.